会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • System and method for selecting a user speech profile for a device in a vehicle
    • 用于为车辆中的设备选择用户语音简档的系统和方法
    • US20070082706A1
    • 2007-04-12
    • US10576842
    • 2004-10-21
    • Douglas CampbellMichael SupanichMark Zeinstra
    • Douglas CampbellMichael SupanichMark Zeinstra
    • H04B1/38
    • B60R16/0373G10L15/07G10L15/22G10L15/26H04M1/271H04M1/6075H04M1/72522
    • A system for selecting a user speech profile for a device in a vehicle includes a control module having a speech recognition system and a memory. The speech recognition system is configured to process audio signals and includes a speaker enrollment function configured to create a user speech profile for at least one user. The memory is configured to store a plurality of user speech profiles created by the speaker enrollment function. The system may include an external device configured to transmit a control signal to the vehicle including an identifier. Alternatively, the system may include a user input device configured to receive an input command from a user that includes an identifier. The control module uses the identifier to select a user speech profile from the plurality of user speech profiles and the speech recognition system uses the selected user speech profile to process audio signals from the user.
    • 用于为车辆中的设备选择用户语音简档的系统包括具有语音识别系统和存储器的控制模块。 语音识别系统被配置为处理音频信号并且包括配置成为至少一个用户创建用户语音简档的扬声器登记功能。 存储器被配置为存储由说话者登记功能创建的多个用户语音简档。 该系统可以包括被配置为向车辆发送包括标识符的控制信号的外部设备。 或者,系统可以包括被配置为从包括标识符的用户接收输入命令的用户输入设备。 控制模块使用标识符从多个用户语音简档中选择用户语音简档,并且语音识别系统使用所选择的用户语音简档来处理来自用户的音频信号。
    • 8. 发明申请
    • Method of cell therapy using fused cell hybrids
    • 使用融合细胞杂交的细胞治疗方法
    • US20060127365A1
    • 2006-06-15
    • US10515579
    • 2003-05-30
    • Victor NurcombeDavid Robert MonaghanDouglas CampbellJohn PriestAlan Watts
    • Victor NurcombeDavid Robert MonaghanDouglas CampbellJohn PriestAlan Watts
    • A61K35/30C12N5/08
    • A61K35/12B03C5/005C12M35/02C12N5/16G01N33/5005G01N33/569G01N2015/1006G01N2015/1081G01N2015/149A61K2300/00
    • The present invention relates generally to the field of tissue engineering and more particularly to a method for generating tissue suitable for use in tissue replacement and/or tissue rejuvenation therapy and/or as a source of cell-derived therapeutic or diagnostic agents including proteins and hormones. Even more particularly, the present invention contemplates the use of cell fusion techniques involving single cell, mini-bulk or macro-bulk cell fusion to generate tissue or cells useful for tissue replacement and/or tissue rejuvenation therapy or a range of organs or areas of the body. The resulting tissue or cells may also secrete or generate a range of cytokines, enzymes, hormones and the like which have improved or more efficacious properties relative to analogous molecules produced from non-fused cells. The present invention further provides an apparatus having aspects controlled by data processing means which facilitates the fusion of a pair of cells. Of the pair of cells, at least one of the cells in the pair may be a mature cell or is capable of differentiating or developing into a mature cell. The subject invention further provides isolated molecules such as cytokines, receptors, antibodies, hormones, heat shock proteins, enzymes, and glycoproteins such as mucins, lectins and heparan sulfates derived from fused cells. These molecules may be characterized by having altered glycosylation patterns, altered post-translational modifications, greater activity, being more efficacious or being more stable relative to analogous molecules from non-fused cells. The present invention further provides novel cell fusates or cell hybrids having a pattern of cell surface markers unique relative to the at least two cells which fuse together to generate the cell. These cell markers are useful in selecting particular cell hybrids and as proprietary tags.
    • 本发明一般涉及组织工程领域,更具体地说,涉及适用于组织置换和/或组织复兴治疗和/或作为细胞来源的治疗或诊断试剂来源的生物组织的方法,包括蛋白质和激素 。 甚至更具体地,本发明考虑使用涉及单细胞,小体积或大体积细胞融合的细胞融合技术来产生可用于组织置换和/或组织复原疗法的组织或细胞或一系列的器官或区域 身体。 所得到的组织或细胞也可以分泌或产生相对于从非融合细胞产生的类似分子具有改善或更有效性质的细胞因子,酶,激素等的范围。 本发明还提供一种具有由数据处理装置控制的方面的装置,其有助于一对单元的融合。 在一对细胞中,该对中的至少一个细胞可以是成熟细胞或能够分化或发育成成熟细胞。 本发明还提供分离的分子,例如细胞因子,受体,抗体,激素,热休克蛋白,酶和糖蛋白,例如来自融合细胞的粘蛋白,凝集素和硫酸乙酰肝素。 这些分子的特征可能是相对于来自非融合细胞的类似分子,具有改变的糖基化模式,改变的翻译后修饰,更大的活性,更有效或更稳定。 本发明还提供了新颖的细胞融合体或细胞杂交体,其具有相对于至少两个细胞独特的细胞表面标志的图案,其融合在一起以产生细胞。 这些细胞标记物可用于选择特定的细胞杂交体和专有标签。